The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $60.20

Today's change+0.68 +1.14%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $60.20

Today's change+0.68 +1.14%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co up (U.S.)$0.68

Bristol-Myers Squibb Co closed up Friday by (U.S.)$0.68 or 1.14% to (U.S.)$60.20. Over the last five days, shares have gained 0.96%, but are down 12.49% for the last year to date. Shares have outperformed the S&P 500 by 11.92% during the last year.

Key company metrics

  • Open(U.S.) $60.20
  • Previous close(U.S.) $59.52
  • High(U.S.) $60.41
  • Low(U.S.) $59.16
  • Bid / Ask-- / --
  • YTD % change-12.49%
  • Volume5,979,602
  • Average volume (10-day)8,372,331
  • Average volume (1-month)8,213,576
  • Average volume (3-month)6,575,862
  • 52-week range(U.S.) $51.82 to (U.S.) $70.87
  • Beta0.53
  • Trailing P/E62.21×
  • P/E 1 year forward25.20×
  • Forward PEG1.21×
  • Indicated annual dividend(U.S.) $1.52
  • Dividend yield2.52%
  • Trailing EPS(U.S.) $0.97
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX2.43%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue4,2874,0694,1634,041
Total other revenue--------
Total revenue4,2874,0694,1634,041
Gross profit3,3352,9873,1753,228
Total cost of revenue9521,082988813
Total operating expense4,3853,2864,1182,752
Selling / general / administrative1,5011,1761,1351,029
Research & development1,9161,0239851,016
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1721801,14498
Other operating expenses, total-156-175-134-204
Operating income-98783451,289
Interest income (expense), net non-operating-43-41-49-51
Gain (loss) on sale of assets-1742088154
Other--------
Income before tax-320987521,448
Income after tax-129730-1101,199
Income tax, total-191257162249
Net income-138706-1301,186
Total adjustments to net income--------
Net income before extra. items-138706-1301,186
Minority interest-9-24-20-13
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-138706-1301,186
Inc. avail. to common incl. extra. items-138706-1301,186
Diluted net income-138706-1301,186
Dilution adjustment--------
Diluted weighted average shares1,6691,6781,6671,676
Diluted EPS excluding extraordinary itemsvalue per share-0.080.42-0.080.71
Dividends per sharevalue per share0.370.370.370.37
Diluted normalized EPSvalue per share0.050.400.430.66